CME Group (CME) is trading down at $269.95 (-0.09%) on NYSE/NASDAQ, as of the latest quote. It is a S&P 500 constituent in the Financials sector.
| FY2016Dec 2016 | FY2017Dec 2017 | FY2018Dec 2018 | FY2019Dec 2019 | FY2020Dec 2020 | FY2021Dec 2021 | FY2022Dec 2022 | FY2023Dec 2023 | FY2024Dec 2024 | FY2025Dec 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | $3.60B | $3.64B | $4.31B | $4.87B | $4.88B | $4.69B | $5.02B | $5.58B | $6.13B | $6.52B |
| Growth (year over year) | +8.1% | +1.4% | +18.2% | +13.0% | +0.3% | −4.0% | +7.0% | +11.1% | +9.9% | +6.4% |
| Operating income | $2.20B | $2.31B | $2.61B | $2.59B | $2.64B | $2.65B | $3.02B | $3.44B | $3.93B | $4.23B |
| Operating margin | 61.2% | 63.4% | 60.5% | 53.2% | 54.0% | 56.4% | 60.1% | 61.6% | 64.1% | 64.9% |
| Net income | $1.53B | $4.06B | $1.96B | $2.12B | $2.11B | $2.64B | $2.69B | $3.23B | $3.53B | $4.07B |
| Net margin | 42.7% | 111.5% | 45.5% | 43.5% | 43.1% | 56.2% | 53.6% | 57.8% | 57.5% | 62.5% |
| EPS (diluted) | $4.53 | $11.94 | $5.71 | $5.91 | $5.87 | $7.29 | $7.40 | $8.86 | $9.67 | $11.16 |
| Balance sheet | ||||||||||
| Cash and equivalents | $1.87B | $1.90B | $1.37B | $1.55B | $1.63B | $2.83B | $2.72B | $2.91B | $2.89B | $4.42B |
| Total assets | $69.4B | $75.8B | $77.5B | $75.2B | $124.7B | $196.8B | $174.2B | $129.7B | $137.4B | $198.4B |
| Total liabilities | $49.0B | $53.4B | $51.5B | $49.1B | $98.3B | $169.4B | $147.3B | $103.0B | $111.0B | $169.7B |
| Shareholders' equity | $20.3B | $22.4B | $26.0B | $26.2B | $26.4B | $27.4B | $26.9B | $26.7B | $26.5B | $28.7B |
| Cash flow | ||||||||||
| Operating cash flow | $1.73B | $1.75B | $2.44B | $2.67B | $2.72B | $2.40B | $3.06B | $3.45B | $3.69B | $4.28B |
| Capital expenditure | $91.8M | $81.9M | $116.7M | $245.6M | $197.5M | $127.2M | $89.7M | $76.4M | $94.0M | $83.5M |
| Free cash flow | $1.64B | $1.67B | $2.32B | $2.43B | $2.52B | $2.28B | $2.97B | $3.38B | $3.60B | $4.19B |
| Dividends paid | $1.79B | $1.99B | $2.15B | $1.70B | $2.11B | $2.19B | $2.63B | $3.24B | $3.58B | $3.93B |
| Q3 FY24Sep 2024 | Q4 FY24†Dec 2024 | Q1 FY25Mar 2025 | Q2 FY25Jun 2025 | Q3 FY25Sep 2025 | Q4 FY25†Dec 2025 | Q1 FY26Mar 2026 | Q2 FY26Jun 2026 | |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | $1.58B | $1.53B | $1.64B | $1.69B | $1.54B | $1.65B | $1.88B | $1.71B |
| Growth (year over year) | +18.4% | +6.0% | +10.4% | +10.4% | −3.0% | +8.1% | +14.5% | +0.8% |
| Operating income | $1.02B | $947.1M | $1.11B | $1.13B | $972.6M | $1.02B | $1.31B | $1.11B |
| Operating margin | 64.6% | 62.1% | 67.5% | 66.7% | 63.3% | 61.8% | 69.7% | 64.9% |
| Net income | $901.3M | $908.0M | $944.2M | $1.03B | $896.6M | $1.21B | $1.17B | $1.04B |
| Net margin | 56.9% | 59.5% | 57.5% | 60.6% | 58.3% | 73.2% | 62.1% | 61.1% |
| EPS (diluted) | $2.50 | $2.40 | $2.62 | $2.81 | $2.49 | $3.24 | $3.18 | $2.88 |
| Balance sheet | ||||||||
| Cash and equivalents | $2.32B | $2.89B | $1.41B | $1.98B | $2.45B | $4.42B | $2.39B | $2.14B |
| Total assets | $137.8B | $137.4B | $157.8B | $179.9B | $187.1B | $198.4B | $202.0B | $194.7B |
| Total liabilities | $109.6B | $111.0B | $130.8B | $152.2B | $159.0B | $169.7B | $175.4B | $168.2B |
| Shareholders' equity | $28.2B | $26.5B | $27.0B | $27.7B | $28.2B | $28.7B | $26.6B | $26.5B |
| Cash flow | ||||||||
| Operating cash flow | $1.00B | $1.02B | $1.12B | $1.06B | $968.1M | $1.13B | $1.26B | $947.1M |
| Capital expenditure | $29.8M | $26.2M | $14.2M | $18.4M | $18.4M | $32.5M | $21.8M | $23.6M |
| Free cash flow | $973.2M | $991.7M | $1.10B | $1.04B | $949.7M | $1.10B | $1.24B | $923.5M |
| Dividends paid | $418.5M | $418.8M | $2.57B | $455.3M | $455.3M | $455.0M | $2.70B | $468.1M |
From CME Group's 10-K and 10-Q filings with the SEC; its fiscal year ends in December. Each period shows the latest figure the company has reported for it, including restatements. † Quarter derived from the company's year-to-date or full-year totals. Filings on SEC EDGAR →
CME Group Inc., headquartered in Chicago, Illinois, operates exchanges and provides clearing services for trading in financial derivatives such as futures contracts, options, and swaps. Its exchanges include the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX), and the Commodity Exchange (COMEX). The company also owns 27% of S&P Dow Jones Indices. The company operates the Globex Trading System, an electronic trading platform that allows customers in approximately 150 countries to trade futures and options contracts. The company also operates two platforms for spot market trading: BrokerTec, which facilitates dealer-to-dealer trading in fixed-income products, and EBS, which provides spot trading in foreign exchange markets. CME Clearing serves as a counterparty to every transaction cleared by the company.
CME Group suspends launch of 10-barrel crude oil futures
CME Group suspends launch of 10-barrel crude oil futures
CME Expands Crypto Futures Lineup With Bitcoin Cash and Uniswap
CME Expands Crypto Futures Lineup With Bitcoin Cash and Uniswap
CME Group to Launch Bitcoin Cash and Uniswap Futures
CME Group to Launch Bitcoin Cash and Uniswap Futures
CME vs. Morningstar: Which Financial Stock Is a Better Buy in 2026?
CME vs. Morningstar: Which Financial Stock Is a Better Buy in 2026?
A $93 trillion trading boom puts CME in an unusual spot
A $93 trillion trading boom puts CME in an unusual spot
CME Group names Jack Tobin as CFO
CME Group names Jack Tobin as CFO